New combo therapy aims to prevent lung damage in tiniest preemies
NCT ID NCT06855043
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a special lung medicine (surfactant mixed with budesonide) to extremely premature babies who are still on a breathing machine at 7-14 days old is safe and can help prevent a serious lung condition called bronchopulmonary dysplasia. About 24 babies will take part. The goal is to see if this late treatment improves breathing and reduces lung injury.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE MECHANICAL VENTILATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
American Family Children's Hospital
Madison, Wisconsin, 53792, United States
-
Meriter Hospital
Madison, Wisconsin, 53715, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can gentle oscillations help premature babies breathe better?
- Could a tiny tube spare preterm babies from breathing machines?
- Can an Oxygen-Boosting drug help when all else fails?
- Can a steroid shot into the windpipe protect preemies' lungs?
- Peer coaching may empower families of Ventilator-Dependent children
- Experimental 'Storm Stopper' therapy tested for COVID-19, flu, and RSV